Back
ZyVersa Therapeutics Stock Price Chart
Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
8
ZVSA
ZyVersa Therapeutics
Last Price:
$0.65
Seasonality Move:
-39.77%
7 Day Trial
ALL ACCESS PASS
$
7
Crowdfunding to IPO: Nasdaq's Next Breakout?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ZVSA is experiencing slight selling pressure.
ZyVersa Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.65 | Sell |
| 20-day SMA: | 0.74 | Sell |
| 50-day SMA: | 1.06 | Sell |
| 200-day SMA: | 2.11 | Sell |
| 8-day EMA: | 0.64 | Sell |
| 20-day EMA: | 0.76 | Sell |
| 50-day EMA: | 0.97 | Sell |
| 200-day EMA: | 18.29 | Sell |
ZyVersa Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 30.07 | Sell |
| Chaikin Money Flow: | -76733 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.64 - 0.98) | Sell |
| Bollinger Bands (100): | (0.86 - 1.4) | Sell |
ZyVersa Therapeutics Technical Analysis
| Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for ZyVersa Therapeutics Stock
Is ZyVersa Therapeutics Stock a Buy?
-
ZyVersa Therapeutics share price is 0.61 while ZVSA 8-day simple moving average is 0.65, which is a Sell signal.
-
The stock price of ZVSA is 0.61 while ZyVersa Therapeutics 20-day SMA is 0.74, which makes it a Sell.
-
ZyVersa Therapeutics 50-day simple moving average is 1.06 while ZVSA share price is 0.61, making it a Sell technically.
-
ZVSA stock price is 0.61 and ZyVersa Therapeutics 200-day simple moving average is 2.11, creating a Sell signal.
ZVSA Technical Analysis vs Fundamental Analysis
Sell
8
ZyVersa Therapeutics (ZVSA)
is a Sell
Is ZyVersa Therapeutics a Buy or a Sell?
-
ZyVersa Therapeutics stock is rated a SellThe current ZyVersa Therapeutics [ZVSA] share price is $0.61. The Score for ZVSA is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
ZyVersa Therapeutics Stock Info
Market Cap:
1.5M
Price in USD:
0.61
Share Volume:
209.3K
ZyVersa Therapeutics 52-Week Range
52-Week High:
8.05
52-Week Low:
0.58
Sell
8
ZyVersa Therapeutics (ZVSA)
is a Sell
ZyVersa Therapeutics Share Price Forecast
-
What is the ZyVersa Therapeutics stock price today?The ZyVersa Therapeutics stock price is 0.61 USD today.
-
Will ZVSA stock go up or go down?ZyVersa Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is ZyVersa Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, ZyVersa Therapeutics is overvalued.
Is ZyVersa Therapeutics Stock a Buy?
-
ZyVersa Therapeutics share price is 0.61 while ZVSA 8-day exponential moving average is 0.64, which is a Sell signal.
-
The stock price of ZVSA is 0.61 while ZyVersa Therapeutics 20-day EMA is 0.76, which makes it a Sell.
-
ZyVersa Therapeutics 50-day exponential moving average is 0.97 while ZVSA share price is 0.61, making it a Sell technically.
-
ZVSA stock price is 0.61 and ZyVersa Therapeutics 200-day simple moving average is 18.29, creating a Sell signal.
Fundamental Analysis of ZyVersa Therapeutics
Is ZyVersa Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $1.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $11.20 per share, and a decrease next year of $0.00 per share.
Technical Analysis of ZyVersa Therapeutics
Should I short ZyVersa Therapeutics stock?
-
ZVSA Moving Average Covergence Divergence (MACD) indicator is -0.13, suggesting ZyVersa Therapeutics is a Sell
-
ZyVersa Therapeutics Relative Strength Index (RSI) is 30.07, which suggest ZyVersa Therapeutics is oversold
-
The Bollinger Bands (25) for ZyVersa Therapeutics is (0.64 - 0.98), which suggest ZyVersa Therapeutics is a Sell
-
The Bollinger Bands (100) for ZyVersa Therapeutics is (0.86 - 1.4), which suggest ZyVersa Therapeutics is a Sell
* ZyVersa Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.